Results 171 to 180 of about 972,269 (340)

Metabolic Syndrome and Atrial Cardiomyopathy on the Risk of Stroke Mortality in the General Population

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 1, January 2026.
Metabolic syndrome and atrial cardiomyopathy each show a positive but statistically non‐significant association with stroke mortality, but their coexistence confers a synergistically higher risk. ABSTRACT Introduction Metabolic syndrome (MetS) and atrial cardiomyopathy (AtCM) are recognized as risk factors for cardiovascular disease, including stroke ...
Yaodongqin Xia   +3 more
wiley   +1 more source

Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study

open access: yesCirculation, 2010
G. Mitchell   +8 more
semanticscholar   +1 more source

Implications of inflammation and sex in lower extremity arterial disease

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
The graphical abstract illustrates the role of inflammation and sex‐related differences in lower extremity artery disease (LEAD). Key inflammatory biomarkers associated with LEAD include C‐reactive protein (CRP), fibrinogen, interleukin‐6 (IL‐6), and D‐dimer, which contribute to vascular inflammation and atherosclerotic plaque formation in lower limb ...
Katja Schnidrig   +7 more
wiley   +1 more source

Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study

open access: yesCirculation, 2004
D. Lloyd‐Jones   +10 more
semanticscholar   +1 more source

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies

open access: gold, 2016
Parag H. Joshi   +12 more
openalex   +1 more source

Heritability of Age at Natural Menopause in the Framingham Heart Study [PDF]

open access: bronze, 2005
Joanne M. Murabito   +4 more
openalex   +1 more source

The Framingham Heart Study: past, present and future [PDF]

open access: yesInternational Journal of Epidemiology, 2015
Connie W, Tsao, Ramachandran S, Vasan
openaire   +2 more sources

Effectiveness of direct oral anticoagulants for all‐cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
This study shows that overweight and obese patients with atrial fibrillation experience improved outcomes when treated with DOACs compared with VKAs. Specifically, DOAC use was associated with lower risks of all‐cause mortality and cardiovascular events.
Danilo Menichelli   +58 more
wiley   +1 more source

Home - About - Disclaimer - Privacy